A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.

@article{Bower2005API,
  title={A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.},
  author={Mark Bower and Brian George Gazzard and Sundhiya Mandalia and Tom Newsom-Davis and Christina Thirlwell and Tony Dhillon and Anne Marie Young and Tom Powles and Andrew Gaya and Mark Nelson and Justin Stebbing},
  journal={Annals of internal medicine},
  year={2005},
  volume={143 4},
  pages={
          265-73
        }
}
Context The International Prognostic Index (IPI) predicts survival in patients with lymphoma, but its applicability to AIDS-related lymphomas in the era of highly active antiretroviral therapy has not been evaluated. The IPI stratifies patients into risk groups on the basis of age, tumor stage, serum lactate dehydrogenase levels, performance status, and number of extranodal sites. Contribution Among 111 patients with AIDS-related lymphoma diagnosed since 1996, the IPI and CD4 cell count… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 46 CITATIONS

Survival outcomes of primary cutaneous T-cell lymphoma in HIV-infected patients: a national population-based study.

  • Journal of investigative medicine : the official publication of the American Federation for Clinical Research
  • 2018

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2004
VIEW 2 EXCERPTS